Recent News
Powered by Alpha Vantage
No recent news found.
AI Tools
Key Metrics
Trend: Downtrend
Source: Snapshot
iBio, Inc., a biotech company, provides contract development and manufacturing services to outside partners and customers in the United States. The company is headquartered in New York, New York.
52W High
$6.89
52W Low
$0.56
MA Status:
50D: Below
200D: Below
Beta (~1 neutral, <0.9 lower risk)
0.86
Valuation
As of 2025-03-31 (Overview)
Trailing P/E (<15 better)
N/A
Forward P/E (<15 better)
N/A
EV/EBITDA (<8 favorable)
-1.59
EV/Revenue (<3 favorable)
40.55
P/S (TTM) (<3 favorable)
43.76
P/B (<3 favorable)
1.44
Ownership
Retail‑heavySource: Overview
Insiders (1–5% typical)
2.86%
Institutions (25–75% balanced)
16.45%
Shares Outstanding
19,654,600
Float
15,639,800
Dividend Yield (2–6% sweet spot)
N/A
Ex‑Dividend Date
N/A
Income & Growth
Profitability: Weak
As of 2025-03-31 (Overview)
Revenue (TTM)
375,000
Gross Profit (TTM)
375,000
EPS (TTM)
-0.04
Profit Margin (>10% good)
N/A
Operating Margin (TTM) (higher better)
-44.83%
ROE (TTM) (>15% strong)
-0.91%
EPS YoY (Quarterly) (>10% good)
N/A
Revenue YoY (Quarterly) (>8% good)
-0.88
Momentum
Bearish momentumValue
0.0595
Previous
0.0552
Trend
Rising
Signal Cross
No cross
As of
Sep. 12, 2025